Articles About Gilead Sciences Inc
April 14, 2014
Merck, Bristol-Myers Squibb, AbbVie, and Gilead Sciences all have hepatitis C cures under development; Gilead's Sovaldi leads, but Merck's drug is competitive.
April 01, 2014
Johnson & Johnson's pharmaceutical unit is seeking FDA approval for a new HIV medicine that contains its darunavir and Gilead's cobicistat.